QUIDEL CORP /DE/0000353569false00003535692020-07-012020-07-0100003535692020-02-122020-02-12


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 1, 2020
 
QUIDEL CORPORATION
(Exact name of Registrant as specified in its Charter)

Delaware
0-10961
94-2573850
 (State or other jurisdiction of incorporation)
 (Commission File Number)
 (IRS Employer Identification No.)

9975 Summers Ridge Road, San Diego, California 92121
(Address of principal executive offices, including zip code)
(858) 552-1100
(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.12a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.001 Par Value QDEL The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.









Item 2.02    Results of Operations and Financial Condition.

        Quidel Corporation (the "Company") issued a press release announcing its preliminary revenue results for the quarter ended June 30, 2020 on July 6, 2020. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K.

        Forward Looking Statements: The financial information set forth in this Form 8-K reflects the company’s current preliminary revenue estimates, is subject to the completion of its review process, and is subject to change. The company’s full second quarter results could differ materially from the preliminary estimates provided in this Form 8-K. You are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date of this Form 8-K. We undertake no obligation to publicly release the results of any revision or update of the forward-looking statements, except as required by law.

Item 5.02     Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 1, 2020, the Compensation Committee of the Board of Directors approved a special grant of RSUs to Werner Kroll, SVP, R&D, in the amount of 2,944 time-based restricted stock units (RSUs). One-third of the RSUs will vest each year on the anniversary of the date of grant, subject to continued employment. This grant was intended to recognize the significant and successful efforts of Dr. Kroll toward the development of the Company’s COVID-19 diagnostic products.

Item 7.01 Regulation FD Disclosure.
As referenced above, in connection with the Company’s press release on July 6, 2020, the Company is reporting on demand for COVID-19 diagnostic products and provided an update on Sofia placements globally.

Item 9.01    Financial Statements and Exhibits.

(d) Exhibits.
The following exhibit is furnished with this current report on Form 8-K:
Exhibit Number Description of Exhibit
99.1
104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL Document


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 6, 2020

QUIDEL CORPORATION
   
By: /s/ Randall J. Steward  
Name: Randall J. Steward  
Its: Chief Financial Officer  


QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more QuidelOrtho Charts.
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more QuidelOrtho Charts.